| Phenotypic variation during biofilm formation: implications for anti-biofilm therapeutic design M Beitelshees, A Hill, CH Jones, BA Pfeifer Materials 11 (7), 1086, 2018 | 80 | 2018 |
| Directed vaccination against pneumococcal disease Y Li, A Hill, M Beitelshees, S Shao, JF Lovell, BA Davidson, PR Knight III, ... Proceedings of the National Academy of Sciences 113 (25), 6898-6903, 2016 | 49 | 2016 |
| Comprehensive vaccine design for commensal disease progression CH Jones, G Zhang, R Nayerhoda, M Beitelshees, A Hill, P Rostami, Y Li, ... Science Advances 3 (10), e1701797, 2017 | 34 | 2017 |
| In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector Y Li, M Beitelshees, L Fang, A Hill, MK Ahmadi, M Chen, BA Davidson, ... Science Advances 2 (7), e1600264, 2016 | 29 | 2016 |
| Engineering a Next-Generation Glycoconjugate-Like Streptococcus pneumoniae Vaccine AB Hill, M Beitelshees, R Nayerhoda, BA Pfeifer, CH Jones ACS infectious diseases 4 (11), 1553-1563, 2018 | 23 | 2018 |
| Vaccine delivery and immune response basics A Hill, M Beitelshees, BA Pfeifer Vaccine Delivery Technology: Methods and Protocols, 1-8, 2021 | 19 | 2021 |
| Pressing diseases that represent promising targets for gene therapy M Beitelshees, A Hill, P Rostami, CH Jones, BA Pfeifer Discovery medicine 24 (134), 313, 2017 | 13 | 2017 |
| Harnessing synthetic biology for advancing RNA therapeutics and vaccine design BA Pfeifer, M Beitelshees, A Hill, J Bassett, CH Jones NPJ Systems Biology and Applications 9 (1), 60, 2023 | 12 | 2023 |
| Enhancing vaccine effectiveness with delivery technology M Beitelshees, Y Li, BA Pfeifer Current opinion in biotechnology 42, 24-29, 2016 | 12 | 2016 |
| Bimodal targeting using sulfonated, mannosylated PEI for combined gene delivery and photodynamic therapy U Chitgupi, Y Li, M Chen, S Shao, M Beitelshees, MJ Tan, ... Photochemistry and photobiology 93 (2), 600-608, 2017 | 7 | 2017 |
| Design variation of a dual-antigen liposomal vaccine carrier system R Nayerhoda, A Hill, M Beitelshees, C Jones, B Pfeifer Materials 12 (17), 2809, 2019 | 3 | 2019 |
| Antigen delivery format variation and formulation stability through use of a hybrid vector M Beitelshees, A Hill, Y Li, M Chen, MK Ahmadi, RJ Smith Jr, ... Vaccine: X 1, 100012, 2019 | 3 | 2019 |
| Standardization of pneumococcal biofilm release to PncO expression, a predictive measurement of virulence A Hill, M Beitelshees, BA Pfeifer, CH Jones Infection and immunity 86 (9), 10.1128/iai. 00494-18, 2018 | 3 | 2018 |
| In silico prediction of pathogen's pandemic potential using the viral trait assessment for pandemics (ViTAP) model CH Jones, M Beitelshees, BA Williams, AB Hill, VL Welch, JM True PNAS nexus 3 (12), pgae558, 2024 | 1 | 2024 |
| Deciphering immune responses: A comparative analysis of influenza vaccination platforms CH Jones, T Hauguel, M Beitelshees, M Davitt, V Welch, K Lindert, ... Drug Discovery Today, 104125, 2024 | 1 | 2024 |
| Assessing the Pandemic Potential of Emerging Avian Influenza A (H5N1) in the United States Using the Viral Trait Assessment for Pandemics (ViTAP) Model C Jones, M Beitelshees medRxiv, 2025.02. 04.25321643, 2025 | | 2025 |
| Defining health equity: A modern US perspective KR Prentice, M Beitelshees, A Hill, CH Jones iScience 27 (12), 2024 | | 2024 |
| Rational Antigen Selection and Delivery Technology for Development of Next Generation Pneumococcal Vaccines M Beitelshees State University of New York at Buffalo, 2019 | | 2019 |
| A Transition to Targeted or ‘Smart’Vaccines: How Understanding Commensal Colonization Can Lead to Selective Vaccination M Beitelshees, A Hill, P Rostami, CH Jones, BA Pfeifer Pharmaceutical Medicine 32, 95-102, 2018 | | 2018 |
Charles JonesIndependent ResearcherVerified email at aktumgroup.com